Active ingredientCiclesonideCat. No. P-C156-001CAS 126544-47-6Family · Pharmaceutical analytical standards
Ciclesonide
A corticosteroid patented in 1990 and approved for medical use in 2005, inhaled to treat asthma and used as a nasal spray for allergic rhinitis (hay fever). This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It is a prodrug: enzymes called esterases, found in human tissues, convert it into its active form, desisobutyryl-ciclesonide.
Go to the active ingredient →Active ingredientCiclesonideCat. No. P-C156-001CAS 126544-47-6
Pharmacopoeial impurityCiclesonide EP Impurity CCat. No. P-C156-002CAS 141845-82-1
Pharmacopoeial impurityCiclesonide EP Impurity B (Mixture of Diastereomers)Cat. No. P-C156-003CAS 204444-44-0
Isotopically labelled21-Desisobutyryl Ciclesonide-D11Cat. No. P-C156-004
Isotopically labelledCiclesonide-D11Cat. No. P-C156-005
Isotopically labelledCiclesonide-d7Cat. No. P-C156-006CAS 1225382-70-6
Impurity21-Desisobutyryl 21-cyclohexanoic acid CiclesonideCat. No. P-C156-007
Impurity21-Desisobutyryl CiclesonideCat. No. P-C156-008CAS 161115-59-9
ImpurityCiclesonide Impurity 1Cat. No. P-C156-009CAS 161115-60-2No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
ImpurityCiclesonide containing impurity A CRSEDQM code Y0001554Family CiclesonideReference substanceCiclesonide CRSEDQM code Y0001553Family CiclesonideImpurityCiclesonide impurity B CRSEDQM code Y0001555Family CiclesonideImpurityCiclesonide impurity C CRSEDQM code Y0001556Family CiclesonideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.